The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 3
- 2 new, 1 renewal
- Median first-year cost
- $299,989
- $1,544,838 in all
- Institutions
- 3
- 3 contact PIs
Awards by fiscal year
0
0
0
0
0
0
0
3
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- BIOLINQ INCORPORATED1
- DIATECH DIABETES, INC.1
- PACIFIC DIABETES TECHNOLOGIES1
Most frequent study sections
- Special Emphasis Panel (ZDK1 GRB-M (M1))3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2021 | Development of a miniaturized single-port automated insulin delivery system utilizing a glucose sensing catheter, ultra-concentrated insulin, and an optimized control algorithm2R44DK123766-02 | Seidl, Thomas Ludwig | PACIFIC DIABETES TECHNOLOGIES, OR | First-year cost $945,509 | Study section ZDK1 |
| FY2021 | Development of a personalized infusion failure detection algorithm combining tissue counter pressure and blood glucose data for closed-loop diabetes management1R43DK130036-01 | Gray, John Clark | DIATECH DIABETES, INC., TN | First-year cost $299,989 | Study section ZDK1 |
| FY2021 | A Hybrid Continuous Glucose and Lactate Monitor with Improved Signal Reliability1R44DK129875-01 | Tangney, Jared Rylan | BIOLINQ INCORPORATED, CA | First-year cost $299,340 | Study section ZDK1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.